GINA WILBER: Open Payments
NPI 1073180550 · HOWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 10 payments from 3 companies in 2025. Trend: 2023 $209 · 2024 $456 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $266 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: INGREZZA, AUSTEDO XR, REXULTI.
Industry payments across NJ — which companies pay providers there.
